
First patient dosed in Phase 2a trial of Nu-3 antimicrobial gel for diabetic foot ulcers
Lakewood-Amedex Biotherapeutics has dosed the first patient in its Phase 2a clinical trial testing Nu-3, a topical antimicrobial gel, for mildly infected diabetic foot ulcers. This trial aims to evaluate the safety and effectiveness of three Nu-3 con...





